Centaur Diagnostics, Inc. — Form D

Centaur Diagnostics, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-08-17. The offering totals $15.9M, of which $15.9M was reported sold. Industry: Other Technology.

Offering

• Filed: 2021-08-17
• Form: D
• Accession: 0001878760-21-000001
• Industry: Other Technology
• Exemptions: 06b
• Total offering: $15.9M
• Amount sold: $15.9M
• Investors: 38
• Date of first sale: 2021-07-30
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-410258

Issuer

• Name: Centaur Diagnostics, Inc.
• CIK: 0001878760
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2017
• Address: 70 NORTHAMPTON STREET, SUITE 306, BOSTON, MA, 02118
• Phone: 508-319-9438

Officers, directors & promoters (2)

More

• CIK 1878760 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search